24 results

• HIV Drug Descovy May Increase Risk of High Blood Pressure: Study

  September 22, 2023

  Irvin Jackson

  Kaiser Permanente researchers warn that the side effects of Descovy could result in an increased risk of hypertension and the need for cholesterol control.

• New HIV Prevention Shot Appears Safer Than Truvada For Women, and More Effective

  November 11, 2020

  Irvin Jackson

  A new injection drug may be safer and more effective at preventing HIV than Truvada, according to clinical trials.

• Kaletra Side Effects Linked To Bradycardia Risk: Study

  July 13, 2020

  Irvin Jackson

  A new study links the side effects of the HIV drug Kaletra to an increased risk of heart rhythm problems.

• Sustiva Pregnancy Risks Include Microcephaly and Developmental Delays: Study

  November 20, 2019

  Martha Garcia

  The findings of a new study suggest that taking the HIV drug Sustiva during pregnancy increases the risk of the child being born with an abnormally small head.

• Descovy Approved As Second HIV Prevention Drug Despite Ongoing Controversies

  October 4, 2019

  Irvin Jackson

  The FDA has approved a new HIV drug, Descovy, for use as a prophylactic to prevent the spread of HIV.

• Truvada for PrEP Bone Fracture Risk Limited, Only High Risk Patients Should Be Concerned: Study

  August 21, 2019

  Irvin Jackson

  A new study finds little risk of bone fractures from Truvada for PrEP use, indicating only those at high risk of fractures already should be concerned.

• Truvada Lawsuit Filed Over Bone Fracture Complications

  July 24, 2019

  Irvin Jackson

  A Truvada lawsuit claims Gilead failed to warn patients that the drug could cause the death of bone tissue due to is high toxicity.

• HIV PrEP Treatment Increased Five-Fold From 2014 to 2017: Report

  July 17, 2019

  Irvin Jackson

  A CDC study found that use of Truvada for HIV prevention increased 500% from 2014 to 2017.

• Lawmakers Question Whether Recent Truvada Donation Came With Backroom Deal Over Drug Patents

  July 3, 2019

  Irvin Jackson

  U.S. lawmakers are wondering whether Gilead's recent donation of millions of bottles of Truvada came with a backdoor deal for the government to drop patent claims on the drug.

• Tivicay Side Effects May Increase Neural Tube Birth Defect Risks, Researchers Warn

  July 27, 2018

  Martha Garcia

  A new study warns that the use of Tivicay, an HIV antiretroviral drug, may increase the risk of neural tube defects when taken by pregnant women before or early in their pregnancy.